Effect of Intensive Segmental Trunk Training on Upper Extremity Function and Seated Postural Stability in Children With Spastic Diplegic Cerebral Palsy

July 2, 2026 updated by: Iqra Khan, University of Lahore

Effect of Intensive Segmental Trunk Training on Upper Extremity Function and Seated Postural Stability in Children With Spastic Diplegic Cerebral Palsy: A Randomized Controlled Trial

The goal of this randomized controlled trial is to evaluate whether intensive segmental trunk training (ISTT) can improve upper extremity function and seated postural stability in children aged 4-12 years with spastic diplegic cerebral palsy and moderate trunk control impairments. The main questions it aims to answer are:

Does intensive segmental trunk training lead to greater improvements in seated postural stability compared to standard physical therapy? Does intensive segmental trunk training lead to greater improvements in upper extremity function compared to standard physical therapy? Researchers compared the ISTT group to the control group (standard physical therapy) to see if the targeted trunk training produces significantly better outcomes in trunk control, upper extremity skills, and gross motor function.

Participants underwent their assigned training regimen five times per week for eight weeks and complete pre- and post-intervention assessments measuring trunk control (SATCo, TCT), upper extremity function (QUEST, Box and Block Test), and gross motor function (GMFM).

Study Overview

Detailed Description

This single-blind randomized controlled trial investigated the efficacy of intensive segmental trunk training (ISTT) as a targeted intervention for improving seated postural control and upper limb function in children with spastic diplegic cerebral palsy (CP). Trunk control deficits are a hallmark impairment in this population, contributing to compromised upper extremity function, reduced seated stability, and limitations in activities of daily living. While conventional physical therapy often addresses trunk control indirectly, this study evaluated whether a structured, segment-specific approach yields superior outcomes.

Thirty children aged 4-12 years with spastic diplegic CP and Gross Motor Function Classification System (GMFCS) levels I-III were recruited from outpatient neurorehabilitation center. Inclusion required moderate trunk control impairment, defined as a score of ≤ 3 on the Trunk Control Test (TCT) item assessing sitting without arm support. Children with uncontrolled seizures, Botulinum toxin injections within the preceding six months, orthopedic surgery within the past year, or cognitive impairment that would preclude task comprehension were excluded.

Participants were randomly assigned to either the ISTT group (n = 15) or the control group (n = 15) using a sealed envelope method with concealed allocation. The ISTT group received specialized training targeting segmental trunk control at the thoracic, lumbar, and pelvic levels. Training sessions, conducted five times weekly for eight weeks (40 sessions total, 45 minutes each), incorporated graded exercises progressing from static to dynamic sitting balance. Key ISTT components included pelvic tilt facilitation, isolated thoracic and lumbar segmental mobilization during weight shifting, trunk rotation with reaching tasks, and perturbation-based reactive balance training using a tilt board. Exercises were progressively advanced based on individual tolerance and performance.

The control group received standard physical therapy of equal duration and frequency, emphasizing neurodevelopmental treatment (NDT) principles, passive stretching of lower extremity muscles, strengthening of the lower limbs, and gait training.

Outcome measures were assessed at baseline, immediately post-intervention (week 8), and at a four-week follow-up. The primary outcomes were seated postural stability, measured by the Segmental Assessment of Trunk Control (SATCo) and the Trunk Control Test (TCT). Secondary outcomes included upper extremity function, assessed via the Quality of Upper Extremity Skills Test (QUEST) and the Box and Block Test (BBT), and gross motor function, measured by the Gross Motor Function Measure (GMFM-88). All assessments were performed by a blinded pediatric physical therapist.

A priori sample size calculation was performed based on pilot data with an effect size of 0.6, alpha of 0.05, and power of 0.80, yielding a minimum of 13 participants per group. Between-group differences were analyzed using repeated measures ANOVA, with post-hoc Bonferroni corrections. Within-group pre-post comparisons used paired t-tests. Effect sizes were calculated using Cohen's d.

The study was approved by the institutional ethics committee. Written informed consent was obtained from parents or legal guardians.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan
        • Pediatric Physical Therapy and Neurorehabilitation Department at the University of Lahore Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Participants included were aged 4-12 years, classified under Gross Motor Function Classification System (GMFCS) Levels II-IV, with ability to sit independently for at least 10 seconds and follow simple verbal instructions. Children with trunk control scores within a moderate impairment range on the Trunk Control Test (TCT) and Segmental Assessment of Trunk Control (SATCo) were included. Parental consent was obtained prior to participation.

Exclusion Criteria:

Children with cognitive impairments severe enough to limit task comprehension, uncontrolled seizures, history of surgical interventions or Botulinum toxin injections in the preceding 6 months, and those receiving other therapeutic interventions targeting trunk control or upper limb function concurrently were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intensive Segmental Trunk Training (ISTT) Group
Participants received specialized segmental trunk training targeting the thoracic, lumbar, and pelvic levels, five times per week for eight weeks (40 sessions, 45 minutes each). Exercises progressed from static to dynamic seated balance and included pelvic tilt facilitation, isolated segmental mobilization during weight shifting, trunk rotation with reaching tasks, and perturbation-based reactive balance training using a tilt board.
A structured, progressive training program targeting segmental trunk control at the thoracic, lumbar, and pelvic levels. Conducted five times per week for eight weeks (40 sessions, 45 minutes each). Exercises progress from static to dynamic seated balance and include pelvic tilt facilitation, isolated segmental mobilization during weight shifting, trunk rotation with reaching tasks, and perturbation-based reactive balance training using a tilt board. Difficulty is advanced based on individual tolerance and performance.
Active Comparator: Control Group (Standard Physical Therapy)
Participants received standard physical therapy of equal duration and frequency (five times per week for eight weeks, 45 minutes per session), emphasizing neurodevelopmental treatment (NDT) principles, passive stretching of lower extremity muscles, lower limb strengthening, and gait training.
Conventional physical therapy based on neurodevelopmental treatment (NDT) principles, involving passive stretching of lower extremity muscles, lower limb strengthening, and gait training. Delivered at the same frequency and duration as the experimental intervention (five times per week, 45 minutes per session, for eight weeks).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Segmental Assessment of Trunk Control (SATCo) - change in seated postural stability
Time Frame: Baseline, immediately post-intervention (Week 8)
A reliable and valid measure that assesses segmental trunk control at cervical, thoracic, and lumbar levels in sitting. Scores range from 0 (no trunk control) to 20 (full segmental trunk control), with higher scores indicating better seated postural stability.
Baseline, immediately post-intervention (Week 8)
Trunk Control Test (TCT) - change in trunk control
Time Frame: Baseline, immediately post-intervention (Week 8)
A standardized test evaluating trunk control ability. Higher scores indicate better trunk control function.
Baseline, immediately post-intervention (Week 8)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Upper Extremity Skills Test (QUEST) - Change in upper extremity function
Time Frame: Baseline, immediately post-intervention (Week 8)
Assesses dissociated movements, grasp, protective extension, and weight bearing in the upper extremities. Scores are expressed as a percentage (0-100%), with higher scores indicating better upper extremity function.
Baseline, immediately post-intervention (Week 8)
Box and Block Test (BBT) - Change in manual dexterity
Time Frame: Baseline, immediately post-intervention (Week 8)
Measures unilateral manual dexterity by counting the number of blocks transferred from one compartment to another within 60 seconds. Higher scores indicate better manual dexterity.
Baseline, immediately post-intervention (Week 8)
Gross Motor Function Measure (GMFM-88) - Change in gross motor function
Time Frame: Baseline, immediately post-intervention (Week 8)
A standardized observational measure assessing gross motor function across five dimensions (lying/rolling, sitting, crawling/kneeling, standing, walking/running/jumping). Scores range from 0 to 100%, with higher scores indicating better gross motor function.
Baseline, immediately post-intervention (Week 8)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2024

Primary Completion (Actual)

October 30, 2024

Study Completion (Actual)

March 30, 2025

Study Registration Dates

First Submitted

July 2, 2026

First Submitted That Met QC Criteria

July 2, 2026

First Posted (Actual)

July 9, 2026

Study Record Updates

Last Update Posted (Actual)

July 9, 2026

Last Update Submitted That Met QC Criteria

July 2, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data related to underlying results, without personal identification, of the individual will be shared on demand. The datasets generated during and/or analysed during the current study will be available upon request from Dr. Iqra Khan, PT, with email address: iqrakhan485@gmail.com Researchers who will provide a reason with proposal of their study can get access

IPD Sharing Time Frame

Immediately following publication and with no end date.

IPD Sharing Access Criteria

The datasets generated during and/or analysed during the current study will be available upon request from Dr. Iqra Khan, PT, with email address: iqrakhan485@gmail.com

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy (CP)

Clinical Trials on Intensive Segmental Trunk Training

3
Subscribe